RuncheyResearch
Back to Forecasting

ADMA Forecast Markets

ADMA Biologics

7
Active Markets
45%
Avg Probability
Price Below Value
Apr 9, 2026

Our prediction ensemble suggests potential upside from current levels.

7 markets analyzedConfidence: MEDIUM
Read Full Thesis

All Markets

7 markets

Will ADMA's days sales outstanding (DSO) remain above 90 days through H1 2026?

Active
57%
Likely Yes
94% agreement
Aug 15, 2026
IG: 0.80

Will ADMA report Q1 2026 revenue above $130M?

Active
75%
Likely Yes
94% agreement
May 15, 2026
IG: 0.64

Will McKesson account for more than 15% of ADMA's revenue by Q4 2026?

Active
25%
Likely No
94% agreement
Mar 15, 2027
IG: 0.64

Will ADMA disclose an SEC formal investigation by year-end 2026?

Active
16%
Likely No
96% agreement
Dec 31, 2026
IG: 0.60

Will ADMA achieve FY2026 revenue above $635M?

Active
58%
Likely Yes
92% agreement
Mar 15, 2027
IG: 0.60

Will CEO Grossman become a net seller of ADMA shares by year-end 2026?

Active
23%
Likely No
94% agreement
Jan 31, 2027
IG: 0.48

Will ADMA's FY2026 gross margin exceed 60%?

Active
62%
Likely Yes
94% agreement
Mar 15, 2027
IG: 0.48

Resolution Timeline

May 15, 2026
Will ADMA report Q1 2026 revenue above $130M?
Prediction: 75%
Aug 15, 2026
Will ADMA's days sales outstanding (DSO) remain above 90 days through H1 2026?
Prediction: 57%
Dec 31, 2026
Will ADMA disclose an SEC formal investigation by year-end 2026?
Prediction: 16%
Jan 31, 2027
Will CEO Grossman become a net seller of ADMA shares by year-end 2026?
Prediction: 23%
Mar 15, 2027
Will McKesson account for more than 15% of ADMA's revenue by Q4 2026?
Prediction: 25%
Mar 15, 2027
Will ADMA achieve FY2026 revenue above $635M?
Prediction: 58%
Mar 15, 2027
Will ADMA's FY2026 gross margin exceed 60%?
Prediction: 62%